Codify — Article

House resolution designates Academic Medicine Week, highlights support needs

Nonbinding resolution recognizes academic medicine’s role from June 23–27, 2025 and urges federal backing for research, residency training, and community partnerships.

The Brief

This resolution designates June 23–27, 2025 as "Academic Medicine Week" and formally recognizes the contributions of academic health systems, medical schools, faculty, trainees, and biomedical researchers to research, patient care, medical education, and community health. It is a sense-of-the-House measure: symbolic recognition coupled with calls for sustained federal support of programs that underpin academic medicine's four missions.

Why it matters: the text marshals membership and funding data to frame academic medicine as a driver of medical research, workforce training, and economic activity, and it explicitly links federal policy levers—Medicare-supported residency slots, HRSA Title VII and VIII programs, and research funding—to preserving access and innovation. For compliance officers and policy teams, the resolution signals likely congressional direction and advocacy priorities even though it creates no binding legal obligations.

At a Glance

What It Does

The resolution declares the week of June 23–27, 2025 "Academic Medicine Week," recites facts about academic medical centers and their missions, and urges federal support for related programs such as Medicare graduate medical education and HRSA pathway grants. It contains no regulatory mandates or appropriations language.

Who It Affects

Primary audiences are academic health systems, medical schools, teaching hospitals, trainees, biomedical researchers, the Department of Veterans Affairs, NIH, HRSA, and congressional appropriations and health-policy staff who track workforce and research funding priorities. Advocacy groups and state health officials may also use the resolution as supporting material.

Why It Matters

Although symbolic, the resolution aggregates data and congressional attention around specific policy levers—GME funding, Title VII/Title VIII programs, and NIH partnerships—signaling priorities that will shape advocacy campaigns, agency briefings, and appropriation debates going forward.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

This House resolution is a nonbinding statement of congressional recognition. It defines a single, week-long observance and uses the preamble to lay out a policy case: academic medical centers perform four interlocking missions—education, research, clinical care, and community collaboration—and those missions together sustain patient access, scientific advancement, and local economies.

The operative clauses formally support the designation, affirm the sector’s impact, call for strong federal support of existing programs, and encourage public recognition.

Practically speaking, the resolution does not create statutory duties or funding streams. Instead it collects and highlights evidence—membership counts, shares of NIH-funded research, workforce projections, and historical VA ties—to justify federal investment.

By naming specific program areas (Medicare-supported residency positions and HRSA Title VII/Title VIII pathway programs), the text frames where Congress should concentrate attention and where stakeholders should direct advocacy and technical assistance.For agencies and institutions, the resolution functions as political and policy context. It may prompt agency briefings, stakeholder meetings, and increased advocacy for budget line items that support graduate medical education, research partnerships, and outreach programs in underserved communities.

For hospitals and medical schools, the resolution strengthens the narrative that federal support is essential, but it does not alter legal or reimbursement rules; operational changes would require separate statutory or regulatory action.

The Five Things You Need to Know

1

The resolution designates June 23–27, 2025 as "Academic Medicine Week.", It cites AAMC membership as nearly 500 academic health systems and 160 medical schools, and highlights the AAMC’s reported counts of faculty, students, residents, and researchers.

2

The preamble states that AAMC-member institutions conduct approximately 60 percent of NIH extramural research and emphasizes the post–World War II NIH–academic partnerships.

3

The text points to a projected physician shortage—citing an AAMC projection of up to 86,000 physicians by 2036—and specifically links increased Medicare support for graduate medical education to addressing shortages in rural and underserved areas.

4

The resolution recalls a 79-year VA–academic medicine partnership and notes the VA’s role as the largest single provider of medical training, with roughly 70 percent of U.S. physicians completing at least part of their training in VA facilities.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Preamble (Whereas clauses)

Data-driven framing of academic medicine’s missions and impact

The preamble assembles a set of factual claims—membership counts, research shares, workforce projections, economic-impact figures, and the VA partnership—to build the policy rationale. Practically, these recitals are the resolution’s argument: they justify subsequent calls for federal support by tying academic medicine to research outputs, workforce training, rural access, and local economies. Stakeholders should note which data points Congress elevates, because those metrics often steer hearings and budget justifications.

Resolved clause 1

Formal designation of Academic Medicine Week (June 23–27, 2025)

This single operative clause establishes a named observance. It creates no legal rights, grant programs, or compliance obligations; the primary effect is symbolic recognition that can be used in outreach, publicity, and stakeholder messaging. State and local actors often echo such federal designations in ceremonies and events, which can amplify advocacy efforts at the community level.

Resolved clause 2

Affirmation of academic medicine’s unique role

This clause affirms the sector’s importance to patients and communities. As a nonbinding statement, it nonetheless signals congressional consensus about the value of academic centers, which committees and appropriators may reference in hearings and reports to justify funding decisions or oversight activities.

2 more sections
Resolved clause 3

Call for strong Federal support of core programs

The resolution explicitly references Medicare-supported residency positions and HRSA Title VII and VIII pathway programs as priorities. While it requests ‘‘strong Federal support’’ rather than prescribing appropriations, naming these programs narrows congressional focus; staffers drafting budget and authorization proposals will likely treat these items as potential areas for legislative or funding action.

Resolved clause 4

Encouragement to the public to recognize academic medicine

This clause invites public acknowledgment and awareness-raising. Its practical effect is to provide cover for outreach campaigns by academic institutions and associations; nonprofits and local health systems can leverage the House’s language in fundraising, recruitment, and community engagement efforts without needing further federal action.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Academic health systems and teaching hospitals — receive congressional recognition and stronger narrative support for funding priorities, which bolsters advocacy for more GME positions and research dollars.
  • Medical students, residents, and postdoctoral researchers — the resolution highlights training pathways and workforce projections, strengthening arguments for increased residency slots and pathway programs that benefit trainees, especially those targeting underserved areas.
  • Department of Veterans Affairs and VA-affiliated training programs — the resolution emphasizes the long-standing VA partnership, supporting continued collaboration and potential advocacy for joint program investments.
  • State and local health departments and rural hospitals — the text spotlights the link between GME funding and rural access, which can be used to justify state or federal initiatives to place residents in underserved communities.
  • Biomedical research stakeholders (NIH-funded investigators and university research offices) — calling out the academic sector’s share of NIH extramural research reinforces arguments for predictable NIH funding and university–federal partnerships.

Who Bears the Cost

  • Federal appropriations committees and agencies (NIH, HRSA, VA, CMS) — although the resolution is symbolic, its policy focus increases pressure on agencies and appropriators to identify funding sources or program expansions, potentially shifting budget priorities.
  • Academic institutions and teaching hospitals — the enhanced expectations for expanding residency slots and community training may impose operational and financial burdens if new funding does not accompany those expectations.
  • State Medicaid programs and safety-net providers — if congressional attention results in program changes that rely on state matching or operational adjustments, state budgets and provider networks could face indirect cost pressures.
  • Advocacy groups and professional associations — the resolution creates incentive to mount campaigns and produce analyses; those activities require staff time and resources even when outcomes are uncertain.

Key Issues

The Core Tension

The central dilemma is symbolic recognition versus substantive commitment: the resolution elevates academic medicine and pinpoints federal levers (GME, HRSA pathways, NIH partnerships) but stops short of funding or policy directives, creating pressure to act without specifying who pays or how progress will be measured.

The resolution walks a narrow line: it marshals detailed statistics and named programs to press a policy agenda, while remaining a nonbinding expression of support. That makes it useful as political cover for advocacy but leaves major open questions.

Most importantly, the text urges ‘‘strong Federal support’’ for Medicare GME and Title VII/Title VIII programs but includes no appropriations language or implementation deadlines; translating congressional encouragement into dollars would require separate statutory or budgetary action.

Another tension lies in the evidence cited. The resolution leans heavily on AAMC-sourced data and long-standing institutional partnerships (for example, with the VA).

Those sources justify federal investment, but they also center well-resourced academic centers in policy debates about access and workforce distribution. Congress could use the same framing to prioritize funding to academic centers rather than community-based providers or alternative training models, with consequences for how physician training capacity and community access evolve.

Operationally, agencies and institutions will face ambiguous next steps. Agencies may be asked to brief committees or provide data; hospitals may be asked to expand residency training; advocacy groups will press appropriators.

Each of those responses carries resource needs and trade-offs that the resolution itself does not resolve.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.